333 related articles for article (PubMed ID: 7570295)
21. Acute rejection: culprit or coincidence in the pathogenesis of cardiac graft vascular disease?
Hauptman PJ; Nakagawa T; Tanaka H; Libby P
J Heart Lung Transplant; 1995; 14(6 Pt 2):S173-80. PubMed ID: 8719481
[No Abstract] [Full Text] [Related]
22. Cytomegalovirus infection-associated immune activation in human blood and heart allografts.
Koskinen P; Krogerus L; Lemström K; Nieminen M; Mattila S; Häyry P; Lautenschlager I
Transplant Proc; 1994 Jun; 26(3):1721-2. PubMed ID: 8030101
[No Abstract] [Full Text] [Related]
23. Role of CD8+ lymphocytes in chronic rejection of transplanted hearts.
Fischbein MP; Yun J; Laks H; Irie Y; Fishbein MC; Bonavida B; Ardehali A
J Thorac Cardiovasc Surg; 2002 Apr; 123(4):803-9. PubMed ID: 11986610
[TBL] [Abstract][Full Text] [Related]
24. Morphology of solid organ allograft arteriopathy: identification of proliferating intimal cell populations.
Demetris AJ; Zerbe T; Banner B
Transplant Proc; 1989 Aug; 21(4):3667-9. PubMed ID: 2669277
[No Abstract] [Full Text] [Related]
25. The composition of ectopic lymphoid structures suggests involvement of a local immune response in cardiac allograft vasculopathy.
Huibers MM; Gareau AJ; Vink A; Kruit R; Feringa H; Beerthuijzen JM; Siera-de Koning E; Peeters T; de Jonge N; de Weger RA; Lee TD
J Heart Lung Transplant; 2015 May; 34(5):734-45. PubMed ID: 25655346
[TBL] [Abstract][Full Text] [Related]
26. Accelerated graft arteriosclerosis is enhanced by sensitization of the recipient to donor lymphocytes.
Cramer DV; Qian S; Harnaha J; Chapman FA; Starzl TE; Makowka L
Transplant Proc; 1989 Aug; 21(4):3714-5. PubMed ID: 2669282
[No Abstract] [Full Text] [Related]
27. The significance for chronic rejection of cardiac allograft of regulated upon activation normal T-cell cytokine and its CCR5 receptor.
Zhao H; Zhang Y; Song G; Zhao W; Bai X; Zhang J; Zhao X
Transplant Proc; 2013 Mar; 45(2):635-8. PubMed ID: 23498802
[TBL] [Abstract][Full Text] [Related]
28. Diminished lymphocyte growth from endomyocardial biopsies from cardiac transplant patients on FK 506 immunosuppression.
Chen-Woan M; Zerbe TR; Zeevi A; Kaufman C; Mallick C; Warty VJ; Griffith BP; Kormos RL; Armitage J; Duquesnoy RJ
Transplant Proc; 1991 Dec; 23(6):2941-2. PubMed ID: 1721320
[No Abstract] [Full Text] [Related]
29. Blockade of very late antigen-4 integrin binding to fibronectin with connecting segment-1 peptide reduces accelerated coronary arteriopathy in rabbit cardiac allografts.
Molossi S; Elices M; Arrhenius T; Diaz R; Coulber C; Rabinovitch M
J Clin Invest; 1995 Jun; 95(6):2601-10. PubMed ID: 7539456
[TBL] [Abstract][Full Text] [Related]
30. A novel effect of cyclosporine A on lymphocyte migration to allograft and recipient lymphoid tissue.
Maksymowicz M; Ziolkowska A; Janczewska S; Cybulska E; Olszewski WL
Transplant Proc; 1998 Dec; 30(8):4054-6. PubMed ID: 9865292
[No Abstract] [Full Text] [Related]
31. Prevention of cardiac allograft arteriosclerosis by protein-tyrosine kinase inhibitor selective for platelet-derived growth factor receptor.
Koskinen P; Sihvola R; Myllärniemi M; Häyry P; Buchdunger E; Lemström K
Transplant Proc; 1999; 31(1-2):102. PubMed ID: 10083029
[No Abstract] [Full Text] [Related]
32. Sudden death caused by bradycardia and asystole in a heart transplant patient with coronary arteriopathy.
Grinstead WC; Smart FW; Pratt CM; Weilbaecher DG; Sekela ME; Noon GP; Young JB
J Heart Lung Transplant; 1991; 10(6):931-6. PubMed ID: 1756158
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic approaches in chronic rejection and cardiac vascularization reinjury.
Häyry P
Transplant Proc; 1996 Dec; 28(6):3435-6. PubMed ID: 8962339
[No Abstract] [Full Text] [Related]
34. Prolongation of cardiac allograft survival following intraportal injection of donor antigen is inhibited by cyclosporine A.
Farges O; Buffello D; Shi YM; Moufetier A; Bismuth H
Transplant Proc; 1995 Aug; 27(4):2525-7. PubMed ID: 7652915
[No Abstract] [Full Text] [Related]
35. Concordance of mRNA expression and protein production of IL-2 and IL-4 by human heart graft-infiltrating lymphocytes.
van Besouw NM; Daane CR; Baan CC; Mol WM; Vaessen LM; Niesters HG; Jutte NH; Weimar W
Transplant Proc; 1995 Feb; 27(1):488. PubMed ID: 7879071
[No Abstract] [Full Text] [Related]
36. Introduction to Lymphocyte Trafficking in Disease.
Lalor PF; Hepburn EA
Methods Mol Biol; 2017; 1591():169-176. PubMed ID: 28349482
[TBL] [Abstract][Full Text] [Related]
37. Indirect alloreactivity and chronic rejection.
Ardehali A; Fischbein MP; Yun J; Irie Y; Fishbein MC; Laks H
Transplantation; 2002 Jun; 73(11):1805-7. PubMed ID: 12085005
[TBL] [Abstract][Full Text] [Related]
38. Lymphocyte culture from routine endomyocardial biopsies: lack of clinical or pathological correlations.
Harcombe A; Cary N; Mullins P; Schofield PM; Large SR; Wallwork J; Weissberg PL; Borysiewicz LK
Transplant Proc; 1993 Feb; 25(1 Pt 1):99. PubMed ID: 8438505
[No Abstract] [Full Text] [Related]
39. Elafin, a serine elastase inhibitor, attenuates post-cardiac transplant coronary arteriopathy and reduces myocardial necrosis in rabbits afer heterotopic cardiac transplantation.
Cowan B; Baron O; Crack J; Coulber C; Wilson GJ; Rabinovitch M
J Clin Invest; 1996 Jun; 97(11):2452-68. PubMed ID: 8647937
[TBL] [Abstract][Full Text] [Related]
40. Cyclosporine control of recipient lymphocyte traffic to the heart allograft.
Maksymowicz M; Olszewski WL
Transplant Proc; 1996 Dec; 28(6):3441-3. PubMed ID: 8962342
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
